Insiders Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
9.5 ^CHF	0.00%		+4.28%	-3.16%

Apr. 25	Transcript : Santhera Pharmaceuticals Holding AG, 2023 Earnings Call, Apr 25, 2024
Apr. 25	Santhera Pharmaceuticals Swings to Profit in FY23; Revenue Grows	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Santhera Pharmaceuticals Names Chief Commercial, Technology Officers	Dec. 07	MT
Santhera Pharmaceuticals Holding Ag Promotes Promotion of Geert Jan Van Daal to Chief Commercial Officer and of Marc Schrader to Chief Technology Officer	Dec. 07	CI
Santhera Pharmaceuticals Holding AG Announces Executive Changes	23-06-27	CI
Santhera Pharmaceuticals Holding AG Announces Board Changes	22-06-30	CI
Santhera Nominates Thomas Meier, PhD, to Succeed Elmar Schnee as Chairman of the Board	22-06-27	DJ
Santhera Pharmaceuticals Holding AG Announces that Elmar Schnee will not stand for re-election at the upcoming Annual General Meeting	22-06-27	CI
Santhera Pharmaceuticals Names New Chief Medical Officer	22-04-13	MT
Santhera Pharmaceuticals Holding AG Appoints Shabir Hasham as Chief Medical Officer and a Member of Santhera’s Executive Management Team, Effective May 1, 2022	22-04-13	CI
Santhera Pharmaceuticals Holding AG Appoints Stephanie Brown as President North America and Member of Executive Management, Effective December 1, 2021	21-11-04	CI
Santhera Announces Departure of Kristina Sjöblom Nygren, Chief Medical Officer and Head of Development	20-11-02	CI
Santhera Pharmaceuticals Approves New Members of the Compensation Committee	20-04-22	CI
Santhera Pharmaceuticals Holding AG Announces Appointment of Andrew Smith as CFO and Member of the Executive Management Team, Effective April 1, 2020	20-01-24	CI
Santhera Pharmaceuticals Appoints Dario Eklund as CEO and to Chair of Board of Director’s Scientific Committee	19-11-04	CI
Christoph Rentsch to Step Down as Chief Financial Officer of Santhera Pharmaceuticals	19-08-09	CI
Jürg Ambühl Decides Not to Stand for Re-Election to the Board of Santhera Pharmaceuticals Holding AG	17-03-07	CI
Santhera Pharmaceuticals Opens of U.S. Office in Burlington, MA; Appoints Todd Bazemore to Lead U.S. Operations in Burlington, MA	17-02-24	CI
Santhera Pharmaceuticals Holding AG Announces Nomination of Directors	17-01-31	CI
Santhera Pharmaceuticals Announces Executive Changes	16-10-04	CI
Santhera Pharmaceuticals Holding AG Appoints as CFO and Member of the Executive Management Team	15-06-22	CI
Santhera Pharmaceuticals Announces Management Changes	15-01-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Santhera Pharmaceuticals Holding AG

Equities

SANN

CH1276028821

Insiders

Filters